Accutar Biotech Stock
HealthTechLooking to sell Accutar Biotech stock or options?
Accutar Biotech is a developer of bio-pharmaceutical technology, aimed at hastening the process of drug discovery. The company employs computational drug design, supplemented by wet-lab validation. They offer services like ligand docking with side-chain flexibility, virtual screening, and prediction of a drug's ADME properties. This facilitates researchers in significantly reducing the time and expense typically involved in traditional drug discovery processes.
Hedosophia, CMS Ventures, Karista (Paris), YITU, Mirae Asset Capital, 5Y Capital, Yunfeng Capital, 3W Partners Capital, Newton BioCapital, Primavera Capital Group, CDH Investments, ZhenFund, IDG Capital, Primavera Venture Partners, Coatue Management.